Literature DB >> 31145663

Survivorship and Outcome of Hip Arthroscopy for Femoroacetabular Impingement Syndrome Performed With Modern Surgical Techniques.

Shane J Nho1, Edward C Beck1, Benedict U Nwachukwu1, Gregory L Cvetanovich2, William H Neal1, Joshua D Harris3, Alexander E Weber4, Richard C Mather5.   

Abstract

BACKGROUND: Hip arthroscopy for femoroacetabular impingement syndrome (FAIS) is a rapidly growing field in sports surgery; however, factors associated with poor outcomes and identification of predictor models of inferior clinical outcomes is unclear.
PURPOSE: To analyze predictors of clinical failure and inferior clinical outcomes among patients undergoing hip arthroscopy for treatment of FAIS. STUDY
DESIGN: Case-control study; Level of evidence, 3.
METHODS: Data were collected and analyzed from consecutive patients who underwent primary hip arthroscopy with routine capsular closure for the treatment of FAIS from a single fellowship-trained surgeon between January 2012 and November 2015. Baseline data, postoperative patient-reported outcomes, and rates of clinical failure and inferior clinical outcomes were recorded at 2 years postoperatively. Clinical failure was defined by revision hip arthroscopy or conversion to total hip arthroplasty. Inferior clinical outcome was defined as not reaching the minimal clinically important difference (MCID) or patient acceptable symptomatic state for Hip Outcome Score-Activities of Daily Living. A multivariate logistic regression analysis was used to identify significant predictors of clinical failure and inferior clinical outcome.
RESULTS: Out of 1161 eligible patients, 935 (80.5%) completed 2-year postoperative patient-reported outcomes. The mean ± SD age and body mass index were 33.3 ± 12.3 years and 25.4 ± 8.2 kg/m2, respectively. The overall clinical failure rate was 3.6% (n = 34), including 23 cases (2.5%) of revision hip arthroscopy and 11 cases (1.2%) of conversion to total hip arthroplasty. Predictors of clinical failure were lower preoperative International Hip Outcome Tool score ( P = .016), chronic preoperative pain ( P = .001), and chondromalacia in the affected hip ( P = .04). The inferior clinical outcome group, consisting of those who failed to reach the MCID for Hip Outcome Score-Activities of Daily Living, included 256 patients (27.4%). Predictors of inferior clinical outcomes were Tönnis grade >1 ( P = .01), workers' compensation ( P < .001), and increased body mass index ( P = .02).
CONCLUSION: This study demonstrates that 73% of all patients treated for symptomatic FAIS with primary hip arthroscopy and routine capsular closure achieved the MCID. Clinical failure is predicted by a number of modifiable and nonmodifiable factors, including chronic preoperative pain and presence of chondromalacia. The current study updates the midterm failure rates and outcomes achievable with hip arthroscopy for FAIS.

Entities:  

Keywords:  FAI; complications; failure; femoroacetabular impingement; hip arthroscopy; outcomes; survivorship

Year:  2019        PMID: 31145663     DOI: 10.1177/0363546519843936

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  15 in total

Review 1.  Approach to a Failed Hip Arthroscopy.

Authors:  Michelle E Arakgi; Ryan M Degen
Journal:  Curr Rev Musculoskelet Med       Date:  2020-06

2.  A T-capsulotomy provides increased hip joint visualization compared with an extended interportal capsulotomy: commentary response.

Authors:  Edward C Beck; Gregory L Cvetanovich; David M Levy; Alexander E Weber; Benjamin D Kuhns; Mahmoud M Khair; Jonathan Rasio; Shane J Nho
Journal:  J Hip Preserv Surg       Date:  2019-11-23

3.  Hip arthroscopy for femoroacetabular impingement is associated with significant improvement in early patient reported outcomes: analysis of 4963 cases from the UK non-arthroplasty registry (NAHR) dataset.

Authors:  Richard Holleyman; Mark Andrew Sohatee; Stephen Lyman; Ajay Malviya; Vikas Khanduja
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-07-14       Impact factor: 4.114

Review 4.  Improvement in pain and patient-related outcome measures following hip arthroscopy in patients with femoroacetabular impingement syndrome and concomitant generalized ligamentous laxity: a systematic review.

Authors:  Xi Ming Zhu; Asra Toobaie; Alla Iansavichene; Moin Khan; Ryan M Degen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-05-23       Impact factor: 4.114

5.  Healing of joint capsule after hip arthroscopy using interportal capsulotomy and capsular closure influences clinical outcomes.

Authors:  Guanying Gao; Chenbo Jiao; Jiayang Liu; Chang Zhou; Yuhao Liu; Yingfang Ao; Yan Xu
Journal:  J Orthop Surg Res       Date:  2022-06-15       Impact factor: 2.677

6.  Hip Arthroscopy for Femoroacetabular Impingement: Minimal Clinically Important Difference Rates Decline From 1- to 5-Year Outcomes.

Authors:  Berkcan Akpinar; Lawrence J Lin; David A Bloom; Thomas Youm
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-01-30

7.  Risk Factors for Conversion of Hip Arthroscopy to Total Hip Arthroplasty: A Large Closed-Cohort Study.

Authors:  Sachin Allahabadi; Adrian D Hinman; Brandon H Horton; Andrew L Avins; Monica J Coughlan; David Y Ding
Journal:  Arthrosc Sports Med Rehabil       Date:  2020-10-15

8.  Arthroscopic Correction of Sports-Related Femoroacetabular Impingement in Competitive Athletes: 2-Year Clinical Outcome and Predictors for Achieving Minimal Clinically Important Difference.

Authors:  Karen Mullins; David Filan; Patrick Carton
Journal:  Orthop J Sports Med       Date:  2021-03-04

Review 9.  Evaluation of outcome reporting trends for femoroacetabular impingement syndrome- a systematic review.

Authors:  Ida Lindman; Sarantos Nikou; Axel Öhlin; Eric Hamrin Senorski; Olufemi Ayeni; Jon Karlsson; Mikael Sansone
Journal:  J Exp Orthop       Date:  2021-04-23

10.  Preoperative Hip Extension Strength Is an Independent Predictor of Achieving Clinically Significant Outcomes After Hip Arthroscopy for Femoroacetabular Impingement Syndrome.

Authors:  Edward C Beck; Benedict U Nwachukwu; Laura M Krivicich; Philip Malloy; Sunikom Suppauksorn; Kyleen Jan; Shane J Nho
Journal:  Sports Health       Date:  2020-05-11       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.